Banco BTG Pactual’s Gilead Sciences GILD Stock Holding History

Banco BTG Pactual’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,000	Closed	-$976K	–	222
2026 Q1	$976K	Buy	+7,000	New	+$980K	0.09%	114

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Banco BTG Pactual's GILD Position: Q2 2026 in Review

Banco BTG Pactual sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 3,144 shares — an estimated $438K sold.

Banco BTG Pactual first reported a position in GILD in Q1 2020 and held it in 3 quarters. The position peaked at $748K in Q1 2020. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Banco BTG Pactual reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
Banco BTG Pactual sold 3,144 Gilead Sciences shares in Q2 2026, an estimated $438K.
Banco BTG Pactual first reported a position in Gilead Sciences in Q1 2020 and held it in 3 quarters.
Banco BTG Pactual's Gilead Sciences position peaked at $748K in Q1 2020.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Banco BTG Pactual's 13F filing for Q2 2026, filed 7 Aug 2026.